Not checked for notices yet.

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results1

Xiaohong Yang, Sang-Rok Lee, Yun-Seok Choi and 6 more

Journal of Lipid Research · 2016

doi:10.1194/jlr.m066399

Cited by papers we hold 3

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention · 2022
No notice
Opportunities and challenges for antisense oligonucleotide therapies · 2020
No notice
Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III · 2017
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.